Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

AVE 0010

Known as: AVE-0010, AVE0010 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Abstract: Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly being used for the treatment of… Expand
  • table 1
  • table 2
2016
2016
Lixisenatide (AVE0010) is a once-daily glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type 2 diabetes… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 5
  • table 1
2015
2015
This was a subanalysis of Japanese patients included in the glucagon‐like peptide‐1 receptor agonist AVE0010 in patients with… Expand
2014
2014
  • S. Bain
  • Diabetes Therapy
  • 2014
  • Corpus ID: 18574167
AbstractLixisenatide (AVE0010) is a once-daily glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type 2… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 2
2008
2008
We recently showed that insulin analogues exhibit a beta-cell protective function. The aim of this study was to test if the anti… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2008
2008
  • U. Werner
  • Annales d'endocrinologie
  • 2008
  • Corpus ID: 30452294
Glucagon-like peptide-1 (GLP-1) is an incretin hormone that is secreted by cells of the lower gastro-intestinal tract following… Expand